MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patients.
<h4>Background</h4>In recent years, microRNA (miRNA) pathways have emerged as a crucial system for the regulation of tumorogenesis. miR-SNPs are a novel class of single nucleotide polymorphisms that can affect miRNA pathways.<h4>Design and methods</h4>We analyzed eight miR-SN...
Guardado en:
Autores principales: | Alfons Navarro, Carmen Muñoz, Anna Gaya, Marina Díaz-Beyá, Bernat Gel, Rut Tejero, Tania Díaz, Antonio Martinez, Mariano Monzó |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a74ca904399d4e798d20c7d4df13c8cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma.
por: Rut Tejero, et al.
Publicado: (2014) -
Epigenetic Regulation of miR-92a and TET2 and Their Association in Non-Hodgkin Lymphoma
por: Esther K. Elliott, et al.
Publicado: (2021) -
Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma.
por: Kazuma Ohyashiki, et al.
Publicado: (2011) -
Efficacies and Toxicities of Seven Chemotherapy Regimens for Advanced Hodgkin Lymphoma
por: Fajun Pei, et al.
Publicado: (2021) -
Hodgkin's lymphoma
por: E. A. Demina, et al.
Publicado: (2020)